[Long-term effects of glipizide at the pancreatic and extra-pancreatic level in non-insulin dependent diabetics].
D000328:Adult; D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004912:Erythrocytes / Q000378:metabolism; D005260:Female; D005913:Glipizide / Q000627:therapeutic use*; D005934:Glucagon / Q000097:blood; D006442:Glycated Hemoglobin / Q000032:analysis*; D006801:Humans; D007328:Insulin / Q000097:blood; D007515:Islets of Langerhans / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D011972:Receptor, Insulin / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000627:therapeutic use*
D001786:Blood Glucose; D005913:Glipizide; D005934:Glucagon; D006442:Glycated Hemoglobin; D007328:Insulin; D011972:Receptor, Insulin; D013453:Sulfonylurea Compounds
Efectos a largo plazo de glipizida a nivel pancreático y extrapancreático en diabéticos insulino-dependientes.